ACET (Adicet Bio, Inc.) Stock Financials & Earnings | Market Cap Arena

ACET (Adicet Bio, Inc.) Stock Financials & Earnings | Market Cap Arena

ACETAdicet Bio, Inc.

Mkt Cap$76M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$115M

EPS (TTM)-$20.16

Free Cash Flow (TTM)-$100M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$0	$0	-$32M
Q1 23	$0	$0	-$33M
Q2 23	$0	$0	-$35M
Q3 23	$0	$0	-$52M
Q4 23	$0	$0	-$32M
Q1 24	$0	-$2M	-$31M
Q2 24	$0	$0	-$33M
Q3 24	$0	$0	-$33M
Q4 24	$0	$0	-$31M
Q1 25	$0	$0	-$30M
Q2 25	$0	$0	-$32M
Q3 25	$0	$0	-$28M

Valuation

Quarter	P/S	P/E
Q4 22	3.0x	—
Q1 23	—	—
Q2 23	—	—
Q3 23	—	—
Q4 23	—	—
Q1 24	—	—
Q2 24	—	—
Q3 24	—	—
Q4 24	—	—
Q1 25	—	—
Q2 25	—	—
Q3 25	—	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	-$19M	-$25M
Q1 23	-$24M	-$26M
Q2 23	-$25M	-$26M
Q3 23	-$21M	-$22M
Q4 23	-$23M	-$24M
Q1 24	-$23M	-$23M
Q2 24	-$23M	-$24M
Q3 24	-$22M	-$22M
Q4 24	-$24M	-$24M
Q1 25	-$25M	-$27M
Q2 25	-$27M	-$27M
Q3 25	-$22M	-$23M

Capital Expenditures

CapEx

Quarter	CapEx
Q4 22	$6M
Q1 23	$2M
Q2 23	$2M
Q3 23	$906K
Q4 23	$136K
Q1 24	$239K
Q2 24	$302K
Q3 24	$401K
Q4 24	$176K
Q1 25	$1M
Q2 25	$47K
Q3 25	$209K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	-100.0%	+50.2%
Q1 23	-100.0%	+64.3%
Q2 23	—	+53.7%
Q3 23	—	+127.4%
Q4 23	—	+0.0%
Q1 24	—	-7.4%
Q2 24	—	-5.8%
Q3 24	—	-36.6%
Q4 24	—	-2.6%
Q1 25	—	-3.2%
Q2 25	—	-1.4%
Q3 25	—	-15.7%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$4M	—
Q1 23	$5M	—
Q2 23	$5M	—
Q3 23	$6M	—
Q4 23	$5M	—
Q1 24	$6M	—
Q2 24	$6M	—
Q3 24	$7M	—
Q4 24	$4M	—
Q1 25	$3M	—
Q2 25	$3M	—
Q3 25	$3M	—

OpEx Breakdown

Quarter	R&D	G&A
Q4 22	$25M	$7M
Q1 23	$27M	$7M
Q2 23	$28M	$7M
Q3 23	$26M	$7M
Q4 23	$25M	$7M
Q1 24	$24M	$7M
Q2 24	$26M	$7M
Q3 24	$26M	$7M
Q4 24	$23M	$7M
Q1 25	$23M	$7M
Q2 25	$28M	$4M
Q3 25	$23M	$5M

Revenue Segments

Quarter

Revenue by Geography

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$258M	$0	$258M
Q1 23	$232M	$0	$232M
Q2 23	$205M	$0	$205M
Q3 23	$183M	$0	$183M
Q4 23	$160M	$0	$160M
Q1 24	$248M	$0	$248M
Q2 24	$224M	$0	$224M
Q3 24	$105M	$97M	$202M
Q4 24	$56M	$120M	$176M
Q1 25	$28M	$122M	$150M
Q2 25	$35M	$90M	$125M
Q3 25	$29M	$74M	$103M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 22	3M	+0.0%
Q1 23	3M	+3.1%
Q2 23	3M	+0.0%
Q3 23	3M	+0.1%
Q4 23	3M	+0.1%
Q1 24	5M	+83.7%
Q2 24	6M	+14.6%
Q3 24	6M	+0.2%
Q4 24	5M	-3.3%
Q1 25	6M	+3.6%
Q2 25	6M	+0.0%
Q3 25	6M	+0.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 13	—	—
FY 14	—	—
FY 15	—	—
FY 16	—	—
FY 17	—	—
FY 18	$390K	21
FY 19	$55K	18
FY 20	$221K	81
FY 21	$113K	86
FY 22	$189K	132
FY 23	$0	143
FY 24	$0	152